Company intelligence / Profile preview

Candioli Pharma

Beinasco (Turin Metro Area), Piedmont, Italy

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Candioli Pharma has a broad commercial portfolio in both the veterinary and, to a lesser extent, the human health sectors. Key clinical and market results include EU-authorized probiotics for companion animals, GMP-certified supplements, and rapidly expanding global distribution, but detailed clinical trial data are not available in the public domain[3][5].

Therapeutic areas: NephrologyRheumatologyGastroenterologyOtherDermatologyPsychiatry
Modalities: Small moleculeBiologicNutritional supplement
Industry: Veterinary

Partnerships

Distribution partnerships in 50+ countriesR&D collaboration with a human probiotics manufacturer for Florentero ACTDistributor in Malaysia: Pawxie Sdn Bhd

Beyond the preview

Go deeper on Candioli Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candioli Pharma.

Explore the full profile